0001209191-19-032054.txt : 20190522
0001209191-19-032054.hdr.sgml : 20190522
20190522162500
ACCESSION NUMBER: 0001209191-19-032054
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190520
FILED AS OF DATE: 20190522
DATE AS OF CHANGE: 20190522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BRYNJELSEN SEAN
CENTRAL INDEX KEY: 0001669976
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38738
FILM NUMBER: 19846069
MAIL ADDRESS:
STREET 1: C/O ETON PHARMACEUTICALS, INC.
STREET 2: 21925 W FIELD PKWY #235
CITY: DEER PARK
STATE: IL
ZIP: 60010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eton Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001710340
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 371858472
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21925 W. FIELD PARKWAY
STREET 2: SUITE 235
CITY: DEER PARK
STATE: IL
ZIP: 60010-7208
BUSINESS PHONE: (847) 787-7361
MAIL ADDRESS:
STREET 1: 21925 W. FIELD PARKWAY
STREET 2: SUITE 235
CITY: DEER PARK
STATE: IL
ZIP: 60010-7208
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-20
0
0001710340
Eton Pharmaceuticals, Inc.
ETON
0001669976
BRYNJELSEN SEAN
21925 W FIELD PKWY #235
DEER PARK
IL
60010
1
1
0
0
President & CEO
Common Stock
2019-05-20
4
P
0
1400
7.782
A
1011400
D
Common Stock
2019-05-21
4
P
0
8600
7.9571
A
1020000
D
Common Stock
24940
I
By LLC
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.77
to $7.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and
Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set
forth above.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.90 to $8.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
/s/ W. Wilson Troutman, Attorney-in-fact
2019-05-22